Identification | Back Directory | [Name]
(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE | [CAS]
53872-60-9 | [Synonyms]
TRT EST2 TCS1 TP-2 TV-DI HYDRIDE-T TP-2 (TV-EDI) ravoprost Epoxide Travoprost Epoxide Travoprost Impurity 13 Curved prostate impurity Fluprostenone Lactone Diol TP-2 (TV-EDI) (Travoprost) (+)-FLUPROSTENOL LACTONE DIOL Anti-TERT antibody produced in goat Anti-Telomerase antibody produced in rabbit (3AR,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)-phenoxy)but-1-en-1-yl)hexa (3AR,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)-phenoxy)but-1-en-1-yl)hexahyd (3aR,4R,5R,6aS)-5-Hydroxy-4-((R,E)-3-hydroxy-4-(3-(trifluoroMethyl)phenoxy)but-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE (3aR,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one 2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)- (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-one(N-3) 53872-60-9 (+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE (3aR,?4R,?5R,?6aS)?-Hexahydro-?5-?hydroxy-?4-?[(1E,?3R)?-?3-?hydroxy-?4-?[3-?(trifluoromethyl)?phenoxy]?-?1-?buten-?1-?yl]?-?2H-?cyclopenta[b]?furan-?2-?one | [Molecular Formula]
C18H19F3O5 | [MDL Number]
MFCD22422511 | [MOL File]
53872-60-9.mol | [Molecular Weight]
372.34 |
Chemical Properties | Back Directory | [Boiling point ]
520.6±50.0 °C(Predicted) | [density ]
1.433±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
DMF: 25 mg/ml; DMF:PBS (pH 7.2) (1:10): 100 μg/ml; DMSO: 17 mg/ml; Ethanol: 20 mg/ml | [form ]
A crystalline solid | [pka]
13.34±0.20(Predicted) |
Hazard Information | Back Directory | [Uses]
(3aR,?4R,?5R,?6aS)?-Hexahydro-?5-?hydroxy-?4-?[(1E,?3R)?-?3-?hydroxy-?4-?[3-?(trifluoromethyl)?phenoxy]?-?1-?buten-?1-?yl]?-?2H-?cyclopenta[b]?furan-?2-?one is involved in the preparation of prostaglandin derivatives. |
|
|